Hidradenitis Suppurativa

An Update

Robert A. Lee, Andrew C. Yoon, Joseph Kist

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

HS is a chronic, debilitating inflammatory dermatosis that is often refractory to treatment. Many medical therapies have been tried and some show efficacy. The introduction of new immunosuppressive medications has revolutionized the treatment of psoriasis in dermatology. These therapies have the potential to powerfully abort the molecular signals driving inflammation in HS and perhaps even induce a remission. This may offer patients an alternative to radical excisional surgery. However, more studies are needed to evaluate the long-term effects of these medications, particularly in light of their association with an increased risk of malignancy and infection. Evaluation of treatment efficacy has been hindered by a lack of uniform standards to track treatment response. The classic clinical classification system has limitations but is a useful scheme to guide selection of treatments. Further laboratory studies may be warranted, depending on the clinical presentation (Box 3). While there are many approaches to treating HS, the authors offer an algorithm based on disease severity (Fig. 9). It is important to address many patient-oriented concerns, such as the pain, dampness, and smell associated with draining sinuses. Communication with the patient about expectations is important to direct treatment. Often a multidisciplinary approach involving dermatology, plastic surgery, gynecology, and urology may be necessary to diagnose and treat the disease. Both medical and surgical options should be explored before embarking on therapy.

Original languageEnglish (US)
Pages (from-to)289-306
Number of pages18
JournalAdvances in Dermatology
Volume23
DOIs
StatePublished - 2007
Externally publishedYes

Fingerprint

Hidradenitis Suppurativa
Therapeutics
Dermatology
Smell
Urology
Plastic Surgery
Immunosuppressive Agents
Gynecology
Psoriasis
Skin Diseases
Communication
Inflammation
Pain

ASJC Scopus subject areas

  • Dermatology

Cite this

Hidradenitis Suppurativa : An Update. / Lee, Robert A.; Yoon, Andrew C.; Kist, Joseph.

In: Advances in Dermatology, Vol. 23, 2007, p. 289-306.

Research output: Contribution to journalArticle

Lee, Robert A. ; Yoon, Andrew C. ; Kist, Joseph. / Hidradenitis Suppurativa : An Update. In: Advances in Dermatology. 2007 ; Vol. 23. pp. 289-306.
@article{e5cd91cb162d45eaa852279066a2724b,
title = "Hidradenitis Suppurativa: An Update",
abstract = "HS is a chronic, debilitating inflammatory dermatosis that is often refractory to treatment. Many medical therapies have been tried and some show efficacy. The introduction of new immunosuppressive medications has revolutionized the treatment of psoriasis in dermatology. These therapies have the potential to powerfully abort the molecular signals driving inflammation in HS and perhaps even induce a remission. This may offer patients an alternative to radical excisional surgery. However, more studies are needed to evaluate the long-term effects of these medications, particularly in light of their association with an increased risk of malignancy and infection. Evaluation of treatment efficacy has been hindered by a lack of uniform standards to track treatment response. The classic clinical classification system has limitations but is a useful scheme to guide selection of treatments. Further laboratory studies may be warranted, depending on the clinical presentation (Box 3). While there are many approaches to treating HS, the authors offer an algorithm based on disease severity (Fig. 9). It is important to address many patient-oriented concerns, such as the pain, dampness, and smell associated with draining sinuses. Communication with the patient about expectations is important to direct treatment. Often a multidisciplinary approach involving dermatology, plastic surgery, gynecology, and urology may be necessary to diagnose and treat the disease. Both medical and surgical options should be explored before embarking on therapy.",
author = "Lee, {Robert A.} and Yoon, {Andrew C.} and Joseph Kist",
year = "2007",
doi = "10.1016/j.yadr.2007.07.001",
language = "English (US)",
volume = "23",
pages = "289--306",
journal = "Advances in Dermatology",
issn = "0882-0880",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Hidradenitis Suppurativa

T2 - An Update

AU - Lee, Robert A.

AU - Yoon, Andrew C.

AU - Kist, Joseph

PY - 2007

Y1 - 2007

N2 - HS is a chronic, debilitating inflammatory dermatosis that is often refractory to treatment. Many medical therapies have been tried and some show efficacy. The introduction of new immunosuppressive medications has revolutionized the treatment of psoriasis in dermatology. These therapies have the potential to powerfully abort the molecular signals driving inflammation in HS and perhaps even induce a remission. This may offer patients an alternative to radical excisional surgery. However, more studies are needed to evaluate the long-term effects of these medications, particularly in light of their association with an increased risk of malignancy and infection. Evaluation of treatment efficacy has been hindered by a lack of uniform standards to track treatment response. The classic clinical classification system has limitations but is a useful scheme to guide selection of treatments. Further laboratory studies may be warranted, depending on the clinical presentation (Box 3). While there are many approaches to treating HS, the authors offer an algorithm based on disease severity (Fig. 9). It is important to address many patient-oriented concerns, such as the pain, dampness, and smell associated with draining sinuses. Communication with the patient about expectations is important to direct treatment. Often a multidisciplinary approach involving dermatology, plastic surgery, gynecology, and urology may be necessary to diagnose and treat the disease. Both medical and surgical options should be explored before embarking on therapy.

AB - HS is a chronic, debilitating inflammatory dermatosis that is often refractory to treatment. Many medical therapies have been tried and some show efficacy. The introduction of new immunosuppressive medications has revolutionized the treatment of psoriasis in dermatology. These therapies have the potential to powerfully abort the molecular signals driving inflammation in HS and perhaps even induce a remission. This may offer patients an alternative to radical excisional surgery. However, more studies are needed to evaluate the long-term effects of these medications, particularly in light of their association with an increased risk of malignancy and infection. Evaluation of treatment efficacy has been hindered by a lack of uniform standards to track treatment response. The classic clinical classification system has limitations but is a useful scheme to guide selection of treatments. Further laboratory studies may be warranted, depending on the clinical presentation (Box 3). While there are many approaches to treating HS, the authors offer an algorithm based on disease severity (Fig. 9). It is important to address many patient-oriented concerns, such as the pain, dampness, and smell associated with draining sinuses. Communication with the patient about expectations is important to direct treatment. Often a multidisciplinary approach involving dermatology, plastic surgery, gynecology, and urology may be necessary to diagnose and treat the disease. Both medical and surgical options should be explored before embarking on therapy.

UR - http://www.scopus.com/inward/record.url?scp=36049016113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36049016113&partnerID=8YFLogxK

U2 - 10.1016/j.yadr.2007.07.001

DO - 10.1016/j.yadr.2007.07.001

M3 - Article

VL - 23

SP - 289

EP - 306

JO - Advances in Dermatology

JF - Advances in Dermatology

SN - 0882-0880

ER -